Record Hepatitis Testing in Wales Signals Progress Toward Elimination

New data from Public Health Wales indicates significant advancements in the fight against hepatitis B and C. The latest findings from the Blood Borne Virus (BBV) Annual Surveillance Report reveal record numbers of screenings, diagnoses, and treatments, reinforcing efforts to meet the World Health Organization’s targets for elimination by 2030.

In 2024, a total of 121,874 individuals were screened for hepatitis B, while 103,203 underwent testing for hepatitis C. These figures represent increases of 12 percent and 14 percent, respectively, from the previous year. This upward trend in hepatitis screening is a positive indication of progress towards reducing the prevalence of these viral infections in Wales.

The report highlights that deaths related to both hepatitis B and C remain low, demonstrating the effectiveness of ongoing treatment efforts. The majority of individuals who began treatment for hepatitis C in recent years have successfully cleared the virus, showcasing advancements in medical interventions and patient care.

Public Health Wales emphasizes the importance of continuing these efforts to ensure that more people are tested and treated. The increased screening rates provide a clearer picture of the viral hepatitis landscape in Wales, which is crucial for implementing targeted public health strategies.

The continued focus on hepatitis elimination aligns with global health initiatives that aim to reduce the burden of viral hepatitis worldwide. By increasing awareness and access to testing and treatment, Wales is setting a precedent for other regions working toward similar goals.

As the elimination efforts progress, the collaboration between healthcare providers and public health organizations remains vital. The data serves not only as a benchmark for success but also as a call to action for further improvements in hepatitis management and prevention strategies across Wales.

With sustained efforts, Wales is making strides towards a future where hepatitis B and C are no longer public health concerns.